We have brought together world-class investors that share our aspirations to scale the tallest mountains.
Our investors share our commitment to deliver on the promise of our technology, our mission to pioneer a new approach to programmable therapeutics, and our vision to create therapies for hundreds of genetic diseases affecting millions of patients.
Our RNA Actuating Platform™ (RAP) enables expansive opportunities across multiple therapeutic areas. Given the enormity of the potential, we can’t do it all alone.
We intend for our approach, technology, and unparalleled understanding of regRNAs and gene expression to usher in a new era of genetic medicines.